日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erratum to "Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study": [ESMO Open 9 (2024) 103989]

更正“识别激素受体阳性/HER2阴性乳腺癌新辅助化疗和内分泌治疗引起的治疗反应和分子变化的预测因子:NEOENDO转化研究”:[ESMO Open 9 (2024) 103989]

Schettini, F; Brasó-Maristany, F; Pascual, T; Lorman-Carbó, N; Nucera, S; Bergamino, M; Galván, P; Conte, B; Seguí, E; García Fructuoso, I; Gómez Bravo, R; Rodríguez, A B; Martínez-Sáez, O; Chic, N; Vidal, M; Adamo, B; González-Farre, B; Sanfeliu, E; Cebrecos, I; Mensión, E; Oses, G; Locci, M; Mollà, M; Ganau, S; Jares, P; Vidal-Sicart, S; Muñoz, M; Prat, A

Outcome Assessment in Children and Adolescents With Chronic Pain: An International Clinical Practice Survey

儿童和青少年慢性疼痛的疗效评估:一项国际临床实践调查

Miró, Jordi; Sánchez-Rodríguez, Elisabet; Jensen, Mark P; Liossi, Christina; Lord, Susan M; Gobina, Inese; Skidmore, Nathan; O'Keeffe, Mary; Walker, Susan M; de la Vega, Rocío; Ingelmo, Pablo; Koechlin, Helen; Ståhl, Minna; Stinson, Jennifer; Wicksell, Rikard K; Finley, G Allen; Cebrecos, Jesús; Goubert, Liesbet; Reinoso-Barbero, Francisco; Rosenberger, Daniela C; Pogatzki-Zahn, Esther M

Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial

雌激素受体阳性、HER2阴性早期乳腺癌女性患者接受Elacestrant治疗:术前治疗窗口期ELIPSE试验结果

Vidal, Maria; Falato, Claudette; Pascual, Tomás; Sanchez-Bayona, Rodrigo; Muñoz-Mateu, Montserrat; Cebrecos, Isaac; Gonzalez-Farré, Xavier; Cortadellas, Tomás; Margelí Vila, Mireia; Luna, Miguel A; Siso, Christian; Amillano, Kepa; Galván, Patricia; Bergamino, Milana A; Ferrero-Cafiero, Juan M; Salvador, Fernando; Espinosa Guerrero, Alejandra; Pare, Laia; Sanfeliu, Esther; Prat, Aleix; Bellet, Meritxell

Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancer

年轻女性雌激素受体阳性、HER2阴性乳腺癌的基因组和临床特征

Walbaum, B; Martínez-Sáez, O; Brasó-Maristany, F; Seguí, E; Chic, N; Muñoz I Carrillo, J; Antonio Sola, J; Rey, M; Giménez-Xavier, P; Gómez-Bravo, R; García-Fructuoso, I; Pascual, T; Rodriguez-Hernandez, A; Schettini, F; Bergamino, M; González, M; Angelats, L; Adamo, B; Muñoz, M; Sanfeliu, E; Martínez-Pozo, A; Galván, P; Jares, P; Puig-Butillé, J A; Cebrecos, I; Sánchez, C; Prat, A; Vidal, M

Nanoparticles of non-porphyrinic covalent organic frameworks as contrast agents for photoacoustic imaging

非卟啉共价有机框架纳米颗粒作为光声成像对比剂

Pi-Martín, Irene; Vidaurre-Agut, Carla; Rivero-Buceta, Eva María; Cebrecos, Alejandro; García-Garrigós, Juan José; Jiménez, Noé; Benlloch, José María; Botella, Pablo; Camarena, Francisco

Adverse Reactions Following First-Dose Administration of Co-Crystal of Tramadol-Celecoxib Versus Tramadol Alone for Moderate-To-Severe Acute Pain

首次服用曲马多-塞来昔布复方制剂与单独服用曲马多治疗中重度急性疼痛后不良反应的比较

Morte, Adelaida; Sust, Mariano; Vaqué, Anna; Cebrecos, Jesús; Giménez-Arnau, José María

Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancer

揭示新辅助化疗和内分泌治疗在激素受体阳性/HER2低表达和HER2阴性乳腺癌中引起的临床病理和分子变化

Schettini, F; Nucera, S; Brasó-Maristany, F; De Santo, I; Pascual, T; Bergamino, M; Galván, P; Conte, B; Seguí, E; García Fructuoso, I; Gómez Bravo, R; Rivera, P; Rodríguez, A B; Martínez-Sáez, O; Ganau, S; Sanfeliu, E; González-Farre, B; Vidal Losada, M J; Adamo, B; Cebrecos, I; Mension, E; Oses, G; Jares, P; Vidal-Sicart, S; Mollà, M; Muñoz, M; Prat, A

Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study

识别激素受体阳性/HER2阴性乳腺癌新辅助化疗和内分泌治疗引起的治疗反应和分子变化的预测因子:NEOENDO转化研究

Schettini, F; Brasó-Maristany, F; Pascual, T; Lorman-Carbó, N; Nucera, S; Bergamino, M; Galván, P; Conte, B; Seguí, E; García Fructuoso, I; Gómez Bravo, R; Rodríguez, A B; Martínez-Sáez, O; Chic, N; Vidal, M; Adamo, B; González-Farre, B; Sanfeliu, E; Cebrecos, I; Mensión, E; Oses, G; Locci, M; Mollà, M; Ganau, S; Jares, P; Vidal-Sicart, S; Muñoz, M; Prat, A

Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy

铜绿假单胞菌血流感染并伴有中性粒细胞减少症癌症患者的感染性休克:经验性抗生素治疗的影响

Royo-Cebrecos, Cristina; Laporte-Amargós, Júlia; Peña, Marta; Ruiz-Camps, Isabel; Garcia-Vidal, Carolina; Abdala, Edson; Oltolini, Chiara; Akova, Murat; Montejo, Miguel; Mikulska, Malgorzata; Martín-Dávila, Pilar; Herrera, Fabián; Gasch, Oriol; Drgona, Lubos; Morales, Hugo Manuel Paz; Brunel, Anne-Sophie; García, Estefanía; Isler, Burcu; Kern, Winfried V; Palacios-Baena, Zaira R; de la Calle, Guillermo Maestr; Montero, Maria Milagro; Kanj, Souha S; Sipahi, Oguz R; Calik, Sebnem; Márquez-Gómez, Ignacio; Marin, Jorge I; Gomes, Marisa Z R; Hemmatii, Philipp; Araos, Rafael; Peghin, Maddalena; Del Pozo, Jose L; Yáñez, Lucrecia; Tilley, Robert; Manzur, Adriana; Novo, Andrés; Carratalà, Jordi; Gudiol, Carlota

Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1)

曲马多-塞来昔布共晶体与曲马多或安慰剂治疗口腔手术后急性中重度疼痛的疗效比较:随机、双盲、3期试验(STARDOM1)

Langford, Richard; Pogatzki-Zahn, Esther M; Morte, Adelaida; Sust, Mariano; Cebrecos, Jesús; Vaqué, Anna; Ortiz, Esther; Fettiplace, James; Adeyemi, Shola; López-Cedrún, José Luis; Bescós, Socorro; Gascón, Neus; Plata-Salamán, Carlos